Brother Enterprises (SZ:002562)2022-12-05 02:20Group 1: Company Operations - Brother Vitamin resumed production after a year-long halt for upgrades, receiving government approval for resumption [2] - The production capacity for Vitamin B1 will be released based on sales performance, without a typical trial production phase [2] Group 2: Market Conditions - Vitamin prices have remained stable since the post-holiday increase, with a typical price increase lag of 3-6 months [2] - The average transaction price for products is expected to gradually increase to current levels in the coming months [2] Group 3: Future Outlook - Short-term price stability for vitamin products is anticipated, while long-term trends will depend on competitive dynamics and international pandemic developments [2] - The global demand for contrast agents and raw materials is approximately 7,000 to 8,000 tons, with a growth rate exceeding 10% in emerging markets [3]